Page last updated: 2024-11-05

2-phenylcyclopropan-1-amine and Benign Neoplasms

2-phenylcyclopropan-1-amine has been researched along with Benign Neoplasms in 1 studies

2-phenylcyclopropan-1-amine : A member of the class of cyclopropanes carrying amino and phenyl substituents at positions 1 and 2 respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, YC1
Ma, YC1
Qin, WP1
Ding, LN1
Zheng, YC1
Zhu, YL1
Zhai, XY1
Yang, J1
Ma, CY1
Guan, YY1

Other Studies

1 other study available for 2-phenylcyclopropan-1-amine and Benign Neoplasms

ArticleYear
Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Histone Deacetylase Inhibitors;

2017